(Q47803943)
Statements
1 reference
Optimal timing and dosing intervals of palivizumab in premature neonates: still some work to do. (English)
1 reference
Giovanna Gomirato
1 reference
Paolo Manzoni
1 reference
Ugo Sala
1 reference
Alessandra Coscia
1 reference
Claudio Fabris
1 reference
1 May 2005
1 reference
1 reference
115
1 reference
5
1 reference
1439-40; author reply 1440-1
1 reference